US 12,391,683 B2
Therapeutic compounds and methods
Ashley Katana, Fairview Park, OH (US); and John Otto Link, San Francisco, CA (US)
Assigned to Actio Biosciences, Inc., San Diego, CA (US)
Filed by Actio Biosciences, Inc., San Diego, CA (US)
Filed on Apr. 9, 2024, as Appl. No. 18/630,109.
Application 18/630,109 is a division of application No. 18/363,195, filed on Aug. 1, 2023, granted, now 11,987,577.
Application 18/363,195 is a continuation of application No. PCT/US2023/069762, filed on Jul. 7, 2023.
Claims priority of provisional application 63/385,282, filed on Nov. 29, 2022.
Claims priority of provisional application 63/359,715, filed on Jul. 8, 2022.
Prior Publication US 2024/0287055 A1, Aug. 29, 2024
Int. Cl. C07D 413/14 (2006.01); C07D 413/08 (2006.01)
CPC C07D 413/14 (2013.01) [C07D 413/08 (2013.01)] 20 Claims
 
1. A method for treating a condition selected from a respiratory disease or disorder, a joint disease, pain, bladder dysfunction, and Mendelian disease, comprising administering to a subject a compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a salt thereof.